BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22318764)

  • 1. Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity.
    Patterson AD; Shah YM; Matsubara T; Krausz KW; Gonzalez FJ
    Hepatology; 2012 Jul; 56(1):281-90. PubMed ID: 22318764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure.
    Chen C; Hennig GE; Whiteley HE; Corton JC; Manautou JE
    Toxicol Sci; 2000 Oct; 57(2):338-44. PubMed ID: 11006363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of peroxisome proliferator-activated receptor α in hepatocytes protects against acetaminophen-induced liver injury by activating the IL-6/STAT3 pathway.
    Zhang Z; Yao T; Zhao N; Liu H; Cheng H; Gonzalez FJ; Wang H; Wang G; Qu A; Wang Y
    Int J Biol Sci; 2022; 18(6):2317-2328. PubMed ID: 35414769
    [No Abstract]   [Full Text] [Related]  

  • 4. FGF21 mediates the protective effect of fenofibrate against acetaminophen -induced hepatotoxicity via activating autophagy in mice.
    Zhang Y; Pan Y; Xiong R; Zheng J; Li Q; Zhang S; Li X; Pan X; Yang S
    Biochem Biophys Res Commun; 2018 Sep; 503(2):474-481. PubMed ID: 29730296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editor's Highlight: Metformin Protects Against Acetaminophen Hepatotoxicity by Attenuation of Mitochondrial Oxidant Stress and Dysfunction.
    Du K; Ramachandran A; Weemhoff JL; Chavan H; Xie Y; Krishnamurthy P; Jaeschke H
    Toxicol Sci; 2016 Dec; 154(2):214-226. PubMed ID: 27562556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity.
    Chen C; Krausz KW; Shah YM; Idle JR; Gonzalez FJ
    Chem Res Toxicol; 2009 Apr; 22(4):699-707. PubMed ID: 19256530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels.
    Murray AJ; Panagia M; Hauton D; Gibbons GF; Clarke K
    Diabetes; 2005 Dec; 54(12):3496-502. PubMed ID: 16306367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice deficient in pyruvate dehydrogenase kinase 4 are protected against acetaminophen-induced hepatotoxicity.
    Duan L; Ramachandran A; Akakpo JY; Woolbright BL; Zhang Y; Jaeschke H
    Toxicol Appl Pharmacol; 2020 Jan; 387():114849. PubMed ID: 31809757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic hypoxia-inducible factors inhibit PPARα expression to exacerbate acetaminophen induced oxidative stress and hepatotoxicity.
    Li D; Du Y; Yuan X; Han X; Dong Z; Chen X; Wu H; Zhang J; Xu L; Han C; Zhang M; Xia Q
    Free Radic Biol Med; 2017 Sep; 110():102-116. PubMed ID: 28583670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.
    Ye D; Wang Y; Li H; Jia W; Man K; Lo CM; Wang Y; Lam KS; Xu A
    Hepatology; 2014 Sep; 60(3):977-89. PubMed ID: 24590984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism for peroxisome proliferator-activated receptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes.
    Nakatani T; Tsuboyama-Kasaoka N; Takahashi M; Miura S; Ezaki O
    J Biol Chem; 2002 Mar; 277(11):9562-9. PubMed ID: 11782473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,5,5-trimethyl-hexanoyl-ferrocene diet protects mice from moderate transient acetaminophen-induced hepatotoxicity.
    Moon MS; Kang BH; Krzeminski J; Amin S; Aliaga C; Zhu J; McDevitt EI; Kocher S; Richie JP; Isom HC
    Toxicol Sci; 2011 Dec; 124(2):348-58. PubMed ID: 21908766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).
    Aoyama T; Peters JM; Iritani N; Nakajima T; Furihata K; Hashimoto T; Gonzalez FJ
    J Biol Chem; 1998 Mar; 273(10):5678-84. PubMed ID: 9488698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase.
    Du K; Williams CD; McGill MR; Jaeschke H
    Toxicol Appl Pharmacol; 2014 Nov; 281(1):58-66. PubMed ID: 25218290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TGFβ1 Receptor Antagonist GW788388 Reduces JNK Activation and Protects Against Acetaminophen Hepatotoxicity in Mice.
    McMillin M; Grant S; Frampton G; Petrescu AD; Williams E; Jefferson B; DeMorrow S
    Toxicol Sci; 2019 May; 170(2):549-561. PubMed ID: 31132129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL16 deficiency attenuates acetaminophen-induced hepatotoxicity through decreasing hepatic oxidative stress and inflammation in mice.
    Wang H; Shao Y; Zhang S; Xie A; Ye Y; Shi L; Jin L; Pan X; Lin Z; Li X; Yang S
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):541-549. PubMed ID: 28459937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity.
    Saito C; Lemasters JJ; Jaeschke H
    Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):8-17. PubMed ID: 20423716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PPAR activator docosahexaenoic acid prevents acetaminophen hepatotoxicity in male CD-1 mice.
    Nguyen KA; Carbone JM; Silva VM; Chen C; Hennig GE; Whiteley HE; Manautou JE
    J Toxicol Environ Health A; 1999 Oct; 58(3):171-86. PubMed ID: 10522648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuating Oxidative Stress by Paeonol Protected against Acetaminophen-Induced Hepatotoxicity in Mice.
    Ding Y; Li Q; Xu Y; Chen Y; Deng Y; Zhi F; Qian K
    PLoS One; 2016; 11(5):e0154375. PubMed ID: 27144271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.